期刊
CURRENT MEDICINAL CHEMISTRY
卷 23, 期 23, 页码 2397-2420出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867323666160510123255
关键词
Artemisinin; Dimers of artemisinin; Dimethylaminoparthenolide; Parthenolide; Potential anticancer agents; Sesquiterpene lactones; Thapsigargin
资金
- National Cancer Institute, NIH, Bethesda, MD, USA [P01 CA125066]
- NATIONAL CANCER INSTITUTE [R01CA185301, P01CA125066] Funding Source: NIH RePORTER
Sesquiterpene lactones are of considerable interest due to their potent bioactivities, including cancer cell cytotoxicity and antineoplastic efficacy in in vivo studies. Among these compounds, artesunate, dimethylaminoparthenolide, and L12ADT peptide prodrug, a derivative of thapsigargin, are being evaluated in the current cancer clinical or preclinical trials. Based on the structures of several antitumor sesquiterpene lactones, a number of analogues showing greater potency have been either isolated as natural products or partially synthesized, and some potential anticancer agents that have emerged from this group of lead compounds have been investigated extensively. The present review focuses on artemisinin, parthenolide, thapsigargin, and their naturally occurring or synthetic analogues showing potential anticancer activity. This provides an overview of the advances in the development of these types of sesquiterpene lactones as potential anticancer agents, including their structural characterization, synthesis and synthetic modification, and antitumor potential, with the mechanism of action and structure-activity relationships also discussed. It is hoped that this will be helpful in stimulating the further interest in developing sesquiterpene lactones and their derivatives as new anticancer agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据